139 related articles for article (PubMed ID: 30873749)
1. CTCF regulates the FoxO signaling pathway to affect the progression of prostate cancer.
Shan Z; Li Y; Yu S; Wu J; Zhang C; Ma Y; Zhuang G; Wang J; Gao Z; Liu D
J Cell Mol Med; 2019 May; 23(5):3130-3139. PubMed ID: 30873749
[TBL] [Abstract][Full Text] [Related]
2. The CCCTC-binding factor (CTCF)-forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinoma.
Zhang B; Zhang Y; Zou X; Chan AW; Zhang R; Lee TK; Liu H; Lau EY; Ho NP; Lai PB; Cheung YS; To KF; Wong HK; Choy KW; Keng VW; Chow LM; Chan KK; Cheng AS; Ko BC
J Pathol; 2017 Dec; 243(4):418-430. PubMed ID: 28862757
[TBL] [Abstract][Full Text] [Related]
3. The progression of LNCaP human prostate cancer cells to androgen independence involves decreased FOXO3a expression and reduced p27KIP1 promoter transactivation.
Lynch RL; Konicek BW; McNulty AM; Hanna KR; Lewis JE; Neubauer BL; Graff JR
Mol Cancer Res; 2005 Mar; 3(3):163-9. PubMed ID: 15798096
[TBL] [Abstract][Full Text] [Related]
4. CTCF-induced upregulation of HOXA11-AS facilitates cell proliferation and migration by targeting miR-518b/ACTN4 axis in prostate cancer.
Xing Z; Li S; Liu Z; Zhang C; Bai Z
Prostate; 2020 Apr; 80(5):388-398. PubMed ID: 31971633
[TBL] [Abstract][Full Text] [Related]
5. Downregulated long non-coding RNA LINC00899 inhibits invasion and migration of spinal ependymoma cells via RBL2-dependent FoxO pathway.
Chen QB; Li ZH; Fu Y; Lv NN; Tian N; Han L; Tian Y
Cell Cycle; 2019 Oct; 18(19):2566-2579. PubMed ID: 31432742
[TBL] [Abstract][Full Text] [Related]
6. MiR-96 expression in prostate cancer and its effect on the target gene regulation.
Bao YH; Wang Y; Liu Y; Wang S; Wu B
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4548-4556. PubMed ID: 29131261
[TBL] [Abstract][Full Text] [Related]
7. Loss of FOXO1 Cooperates with TMPRSS2-ERG Overexpression to Promote Prostate Tumorigenesis and Cell Invasion.
Yang Y; Blee AM; Wang D; An J; Pan Y; Yan Y; Ma T; He Y; Dugdale J; Hou X; Zhang J; Weroha SJ; Zhu WG; Wang YA; DePinho RA; Xu W; Huang H
Cancer Res; 2017 Dec; 77(23):6524-6537. PubMed ID: 28986382
[TBL] [Abstract][Full Text] [Related]
8. Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells.
Yan F; Liao R; Farhan M; Wang T; Chen J; Wang Z; Little PJ; Zheng W
Biomed Pharmacother; 2016 Dec; 84():1538-1550. PubMed ID: 27881235
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
Shen PF; Chen XQ; Liao YC; Chen N; Zhou Q; Wei Q; Li X; Wang J; Zeng H
Prostate; 2014 May; 74(7):756-67. PubMed ID: 24644030
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y
Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
Sun B; Fan Y; Yang A; Liang L; Cao J
J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493
[TBL] [Abstract][Full Text] [Related]
12. GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway.
Liang F; Yue J; Wang J; Zhang L; Fan R; Zhang H; Zhang Q
Med Oncol; 2015 Mar; 32(3):49. PubMed ID: 25636507
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-590-3p promotes cell proliferation and invasion by targeting inositol polyphosphate 4-phosphatase type II in human prostate cancer cells.
Chen H; Luo Q; Li H
Tumour Biol; 2017 Mar; 39(3):1010428317695941. PubMed ID: 28345464
[TBL] [Abstract][Full Text] [Related]
14. FOXO1 inhibits prostate cancer cell proliferation via suppressing E2F1 activated NPRL2 expression.
Tang Y; Jiang L; Zhao X; Hu D; Zhao G; Luo S; Du X; Tang W
Cell Biol Int; 2021 Dec; 45(12):2510-2520. PubMed ID: 34459063
[TBL] [Abstract][Full Text] [Related]
15. [FOXO3a signaling pathway in prostate cancer: Progress in studies].
Tao Y; Li LL; Liu SH; Hong M
Zhonghua Nan Ke Xue; 2020 Aug; 26(8):745-750. PubMed ID: 33377739
[TBL] [Abstract][Full Text] [Related]
16. Platycodin D induces tumor growth arrest by activating FOXO3a expression in prostate cancer in vitro and in vivo.
Zhou R; Lu Z; Liu K; Guo J; Liu J; Zhou Y; Yang J; Mi M; Xu H
Curr Cancer Drug Targets; 2015; 14(9):860-71. PubMed ID: 25431082
[TBL] [Abstract][Full Text] [Related]
17. Circulating IGF-1 promotes prostate adenocarcinoma via FOXO3A/BIM signaling in a double-transgenic mouse model.
Wang S; Wang N; Yu B; Cao M; Wang Y; Guo Y; Zhang Y; Zhang P; Yu X; Wang S; Zeng L; Liang B; Li X; Wu Y
Oncogene; 2019 Sep; 38(36):6338-6353. PubMed ID: 31312023
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the anticancer mechanism of ferulic acid via cell cycle and apoptotic pathways in human prostate cancer cell lines.
Eroğlu C; Seçme M; Bağcı G; Dodurga Y
Tumour Biol; 2015 Dec; 36(12):9437-46. PubMed ID: 26124008
[TBL] [Abstract][Full Text] [Related]
19. FOXO transcription factors in cancer development and therapy.
Coomans de Brachène A; Demoulin JB
Cell Mol Life Sci; 2016 Mar; 73(6):1159-72. PubMed ID: 26686861
[TBL] [Abstract][Full Text] [Related]
20. β-arrestin1-medieated inhibition of FOXO3a contributes to prostate cancer cell growth in vitro and in vivo.
Kong Z; Deng T; Zhang M; Zhao Z; Liu Y; Luo L; Cai C; Wu W; Duan X
Cancer Sci; 2018 Jun; 109(6):1834-1842. PubMed ID: 29676828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
